SCHEMBL352916

SCHEMBL352916

CN(Cc1nsc(NC(=O)NCc2ccc(Cl)s2)n1)C(=O)c1cc(Cl)c2c(c1)OCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
CASP6 P55212 1/20 0.33
KMT2A Q03164 4/20 0.33
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
MEN1 O00255 2/20 0.33
MITF O75030 1/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
CPT1A P50416 2/20 0.32
CPT1B Q92523 2/20 0.32
CPT2 P23786 1/20 0.32
SCN9A Q15858 1/20 0.31
ALDH1A1 P00352 2/20 0.31
HTT P42858 2/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19119488 0.88 POLB (0.33) POLBCASP6KDM4ELMNASMN1; SMN2
SCHEMBL353682 0.87 CPT1A (0.40) HPGDPOLBCASP6KMT2ARAB9A
SCHEMBL352616 0.86 ROCK2 (0.41) HPGDKMT2ARAB9ANPC1MEN1
SCHEMBL19119462 0.75 CPT1A (0.37) POLBCASP6KMT2ARAB9ANPC1
SCHEMBL354665 0.75 ALDH1A1 (0.34) KMT2ARAB9ASMN1; SMN2ALDH1A1HTT
SCHEMBL352384 0.75 ALDH1A1 (0.37) HPGDKMT2AMEN1KDM4ELMNA
SCHEMBL353277 0.75 KMT2A (0.36) HPGDKMT2ARAB9AMEN1KDM4E
SCHEMBL353276 0.75 KMT2A (0.36) HPGDKMT2ARAB9AMEN1KDM4E
SCHEMBL352265 0.75 ALDH1A1 (0.41) HPGDKMT2ARAB9ANPC1MEN1
SCHEMBL354448 0.74 KMT2A (0.33) POLBKMT2ARAB9ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US claimed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US claimed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP claimed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed
EP-2200440-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS Crestone, Inc. (US) 2010-06-30 EP disclosed
WO-2009015208-A1 ANTIBACTERIAL AMIDE AND SULFONAMIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA HPGD 1814/4885POLB 1884/4885CASP6 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.